Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau

Ann Van Der Jeugd, Katja Hochgräfe, Tariq Ahmed, Jochen M. Decker, Astrid Sydow, Anne Hofmann, Dan Wu, Lars Messing, Detlef Balschun, Rudi D'Hooge, Eva Maria Mandelkow

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Neurofibrillary lesions of abnormal Tau are hallmarks of Alzheimer disease and frontotemporal dementias. Our regulatable (Tet-OFF) mouse models of tauopathy express variants of human full-length Tau in the forebrain (CaMKIIα promoter) either with mutation ΔK280 (pro-aggregant) or ΔK280/I277P/I308P (anti-aggregant). Co-expression of luciferase enables in vivo quantification of gene expression by bioluminescence imaging. Pro-aggregant mice develop synapse loss and Tau-pathology including missorting, phosphorylation and early pretangle formation, whereas anti-aggregant mice do not. We correlated hippocampal Tau pathology with learning/memory performance and synaptic plasticity. Proaggregant mice at 16 months of gene expression exhibited severe cognitive deficits in Morris water maze and in passive-avoidance paradigms, whereas anti-aggregant mice were comparable to controls. Cognitive impairment of proaggregant mice was accompanied by loss of hippocampal LTP in CA1 and CA3 areas and by a reduction of synaptic proteins and dendritic spines, although no neuronal loss was observed. Remarkably, memory and LTP recovered when pro-aggregant Tau was switched-OFF for ∼4 months, Tau phosphorylation and missorting were reversed, and synapses recovered. Moreover, soluble and insoluble pro-aggregant hTau40 disappeared, while insoluble mouse Tau was still present. This study links early Tau pathology without neurofibrillary tangles and neuronal death to cognitive decline and synaptic dysfunction. It demonstrates that Tau-induced impairments are reversible after switching-OFF pro-aggregant Tau. Therefore, our mouse model may mimic an early phase of AD when the hippocampus does not yet suffer from irreversible cell death but cognitive deficits are already striking. It offers potential to evaluate drugs with regard to learning and memory performance.

Original languageEnglish
Pages (from-to)787-805
Number of pages19
JournalActa Neuropathologica
Volume123
Issue number6
DOIs
Publication statusPublished - Jun 2012
Externally publishedYes

Fingerprint

Pathology
Synapses
Alzheimer Disease
Phosphorylation
Learning
Tauopathies
Gene Expression
Calcium-Calmodulin-Dependent Protein Kinase Type 2
Frontotemporal Dementia
Dendritic Spines
Neurofibrillary Tangles
Neuronal Plasticity
Prosencephalon
Luciferases
Hippocampus
Cell Death
Mutation
Water
Pharmaceutical Preparations
Proteins

Keywords

  • Alzheimer disease
  • Behavior
  • Bioluminescene imaging
  • Long-term potentiation
  • Tau mouse model

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Cellular and Molecular Neuroscience

Cite this

Van Der Jeugd, A., Hochgräfe, K., Ahmed, T., Decker, J. M., Sydow, A., Hofmann, A., ... Mandelkow, E. M. (2012). Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau. Acta Neuropathologica, 123(6), 787-805. https://doi.org/10.1007/s00401-012-0987-3

Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau. / Van Der Jeugd, Ann; Hochgräfe, Katja; Ahmed, Tariq; Decker, Jochen M.; Sydow, Astrid; Hofmann, Anne; Wu, Dan; Messing, Lars; Balschun, Detlef; D'Hooge, Rudi; Mandelkow, Eva Maria.

In: Acta Neuropathologica, Vol. 123, No. 6, 06.2012, p. 787-805.

Research output: Contribution to journalArticle

Van Der Jeugd, A, Hochgräfe, K, Ahmed, T, Decker, JM, Sydow, A, Hofmann, A, Wu, D, Messing, L, Balschun, D, D'Hooge, R & Mandelkow, EM 2012, 'Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau', Acta Neuropathologica, vol. 123, no. 6, pp. 787-805. https://doi.org/10.1007/s00401-012-0987-3
Van Der Jeugd, Ann ; Hochgräfe, Katja ; Ahmed, Tariq ; Decker, Jochen M. ; Sydow, Astrid ; Hofmann, Anne ; Wu, Dan ; Messing, Lars ; Balschun, Detlef ; D'Hooge, Rudi ; Mandelkow, Eva Maria. / Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau. In: Acta Neuropathologica. 2012 ; Vol. 123, No. 6. pp. 787-805.
@article{8dce494b32a7456290a44289cf4f4f86,
title = "Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau",
abstract = "Neurofibrillary lesions of abnormal Tau are hallmarks of Alzheimer disease and frontotemporal dementias. Our regulatable (Tet-OFF) mouse models of tauopathy express variants of human full-length Tau in the forebrain (CaMKIIα promoter) either with mutation ΔK280 (pro-aggregant) or ΔK280/I277P/I308P (anti-aggregant). Co-expression of luciferase enables in vivo quantification of gene expression by bioluminescence imaging. Pro-aggregant mice develop synapse loss and Tau-pathology including missorting, phosphorylation and early pretangle formation, whereas anti-aggregant mice do not. We correlated hippocampal Tau pathology with learning/memory performance and synaptic plasticity. Proaggregant mice at 16 months of gene expression exhibited severe cognitive deficits in Morris water maze and in passive-avoidance paradigms, whereas anti-aggregant mice were comparable to controls. Cognitive impairment of proaggregant mice was accompanied by loss of hippocampal LTP in CA1 and CA3 areas and by a reduction of synaptic proteins and dendritic spines, although no neuronal loss was observed. Remarkably, memory and LTP recovered when pro-aggregant Tau was switched-OFF for ∼4 months, Tau phosphorylation and missorting were reversed, and synapses recovered. Moreover, soluble and insoluble pro-aggregant hTau40 disappeared, while insoluble mouse Tau was still present. This study links early Tau pathology without neurofibrillary tangles and neuronal death to cognitive decline and synaptic dysfunction. It demonstrates that Tau-induced impairments are reversible after switching-OFF pro-aggregant Tau. Therefore, our mouse model may mimic an early phase of AD when the hippocampus does not yet suffer from irreversible cell death but cognitive deficits are already striking. It offers potential to evaluate drugs with regard to learning and memory performance.",
keywords = "Alzheimer disease, Behavior, Bioluminescene imaging, Long-term potentiation, Tau mouse model",
author = "{Van Der Jeugd}, Ann and Katja Hochgr{\"a}fe and Tariq Ahmed and Decker, {Jochen M.} and Astrid Sydow and Anne Hofmann and Dan Wu and Lars Messing and Detlef Balschun and Rudi D'Hooge and Mandelkow, {Eva Maria}",
year = "2012",
month = "6",
doi = "10.1007/s00401-012-0987-3",
language = "English",
volume = "123",
pages = "787--805",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau

AU - Van Der Jeugd, Ann

AU - Hochgräfe, Katja

AU - Ahmed, Tariq

AU - Decker, Jochen M.

AU - Sydow, Astrid

AU - Hofmann, Anne

AU - Wu, Dan

AU - Messing, Lars

AU - Balschun, Detlef

AU - D'Hooge, Rudi

AU - Mandelkow, Eva Maria

PY - 2012/6

Y1 - 2012/6

N2 - Neurofibrillary lesions of abnormal Tau are hallmarks of Alzheimer disease and frontotemporal dementias. Our regulatable (Tet-OFF) mouse models of tauopathy express variants of human full-length Tau in the forebrain (CaMKIIα promoter) either with mutation ΔK280 (pro-aggregant) or ΔK280/I277P/I308P (anti-aggregant). Co-expression of luciferase enables in vivo quantification of gene expression by bioluminescence imaging. Pro-aggregant mice develop synapse loss and Tau-pathology including missorting, phosphorylation and early pretangle formation, whereas anti-aggregant mice do not. We correlated hippocampal Tau pathology with learning/memory performance and synaptic plasticity. Proaggregant mice at 16 months of gene expression exhibited severe cognitive deficits in Morris water maze and in passive-avoidance paradigms, whereas anti-aggregant mice were comparable to controls. Cognitive impairment of proaggregant mice was accompanied by loss of hippocampal LTP in CA1 and CA3 areas and by a reduction of synaptic proteins and dendritic spines, although no neuronal loss was observed. Remarkably, memory and LTP recovered when pro-aggregant Tau was switched-OFF for ∼4 months, Tau phosphorylation and missorting were reversed, and synapses recovered. Moreover, soluble and insoluble pro-aggregant hTau40 disappeared, while insoluble mouse Tau was still present. This study links early Tau pathology without neurofibrillary tangles and neuronal death to cognitive decline and synaptic dysfunction. It demonstrates that Tau-induced impairments are reversible after switching-OFF pro-aggregant Tau. Therefore, our mouse model may mimic an early phase of AD when the hippocampus does not yet suffer from irreversible cell death but cognitive deficits are already striking. It offers potential to evaluate drugs with regard to learning and memory performance.

AB - Neurofibrillary lesions of abnormal Tau are hallmarks of Alzheimer disease and frontotemporal dementias. Our regulatable (Tet-OFF) mouse models of tauopathy express variants of human full-length Tau in the forebrain (CaMKIIα promoter) either with mutation ΔK280 (pro-aggregant) or ΔK280/I277P/I308P (anti-aggregant). Co-expression of luciferase enables in vivo quantification of gene expression by bioluminescence imaging. Pro-aggregant mice develop synapse loss and Tau-pathology including missorting, phosphorylation and early pretangle formation, whereas anti-aggregant mice do not. We correlated hippocampal Tau pathology with learning/memory performance and synaptic plasticity. Proaggregant mice at 16 months of gene expression exhibited severe cognitive deficits in Morris water maze and in passive-avoidance paradigms, whereas anti-aggregant mice were comparable to controls. Cognitive impairment of proaggregant mice was accompanied by loss of hippocampal LTP in CA1 and CA3 areas and by a reduction of synaptic proteins and dendritic spines, although no neuronal loss was observed. Remarkably, memory and LTP recovered when pro-aggregant Tau was switched-OFF for ∼4 months, Tau phosphorylation and missorting were reversed, and synapses recovered. Moreover, soluble and insoluble pro-aggregant hTau40 disappeared, while insoluble mouse Tau was still present. This study links early Tau pathology without neurofibrillary tangles and neuronal death to cognitive decline and synaptic dysfunction. It demonstrates that Tau-induced impairments are reversible after switching-OFF pro-aggregant Tau. Therefore, our mouse model may mimic an early phase of AD when the hippocampus does not yet suffer from irreversible cell death but cognitive deficits are already striking. It offers potential to evaluate drugs with regard to learning and memory performance.

KW - Alzheimer disease

KW - Behavior

KW - Bioluminescene imaging

KW - Long-term potentiation

KW - Tau mouse model

UR - http://www.scopus.com/inward/record.url?scp=84864382491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864382491&partnerID=8YFLogxK

U2 - 10.1007/s00401-012-0987-3

DO - 10.1007/s00401-012-0987-3

M3 - Article

VL - 123

SP - 787

EP - 805

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 6

ER -